<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02471586</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10034</org_study_id>
    <nct_id>NCT02471586</nct_id>
  </id_info>
  <brief_title>OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation</brief_title>
  <acronym>ILUMIEN III</acronym>
  <official_title>ILUMIEN III: OPTIMIZE PCI: OPtical Coherence Tomography (OCT) Compared to Intravascular Ultrasound (IVUS) and Angiography to Guide Coronary Stent Implantation: a Multicenter RandomIZEd Trial in Percutaneous Coronary Intervention (PCI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiovascular Research Foundation, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical investigation is to demonstrate the safety and efficacy of an&#xD;
      OCT guided strategy for stent implantation&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, post-market, international, multi-center, randomized clinical&#xD;
      investigation in which the participants will be randomized in 1:1:1 ratio to undergo PCI with&#xD;
      either OCT, IVUS, or Angiography guidance. The clinical investigation will be conducted at&#xD;
      approximately 35 sites in the United States and outside the United States; approximately 25%&#xD;
      of subjects will be enrolled in the United States.&#xD;
&#xD;
      Patients in the IVUS and OCT groups patients will undergo baseline and post PCI imaging with&#xD;
      their randomized modality. In addition, the Angiography group and IVUS groups will undergo a&#xD;
      blinded post-PCI OCT run to allow comparison of OCT derived minimum stent area (MSA) in both&#xD;
      groups.&#xD;
&#xD;
      After hospital discharge, all patients will have clinical follow-up at 30 days, and 1 year.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">April 25, 2017</completion_date>
  <primary_completion_date type="Actual">April 5, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>For those subjects randomized to the IVUS or Angiography treatment arms, the operating investigator at the site was blinded to the final post-PCI OCT run for the subject.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Efficacy Endpoint (Powered): Post-PCI Median Minimum Stent Area (MSA)</measure>
    <time_frame>Post-procedure within 1 hour</time_frame>
    <description>Post-PCI MSA will be assessed by OCT in each randomized arm, measured at the independent OCT core laboratory blinded to imaging modality assignment. Hierarchal manner testing will be as follows:&#xD;
Non-inferiority: OCT vs. IVUS guided stenting&#xD;
Non-inferiority of OCT guided stenting to IVUS guided stenting will be analyzed for the mean difference between the post PCI MSA for the OCT and IVUS arms with non-inferiority margin of 1.0 mm^2.&#xD;
Superiority: OCT vs. Angiography guided stenting&#xD;
If the OCT guided stenting arm was found to be non-inferior to the IVUS guided stenting arm, the superiority of OCT to angiography will be tested for the mean difference between the post PCI MSA for the OCT and angiography arms.&#xD;
Superiority: OCT vs. IVUS guided stenting&#xD;
If the OCT guided stenting arm was found to be superior to the IVUS guided stenting arm, then the superiority of OCT to IVUS will be tested for the mean difference between the post PCI MSA for the OCT and IVUS arms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Endpoint (Non-powered): Number of Participants With Procedural MACE (Major Adverse Cardiac Event)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Procedural MACE defined as procedural complications (angiographic dissection, perforation, thrombus, and acute closure) requiring active interventions (prolonged balloon inflations, additional stent implantations, pericardiocentesis, thrombus aspiration and other).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Acute Procedural Success</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Acute procedural success are classified as:&#xD;
A) Optimal (%)&#xD;
The MSA of the proximal segment is ≥95% of the proximal reference lumen area and the MSA of the distal segment is ≥95% of the distal reference lumen area.&#xD;
B) Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
C) Optimal and Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
D) Unacceptable (%)&#xD;
The MSA of the proximal segment is &lt;90% of the proximal lumen area, and/or the MSA of the distal segment is &lt;90% of the distal reference lumen area.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Post-PCI Stent Expansion (%)</measure>
    <time_frame>Up to 1 hour post-procedure</time_frame>
    <description>Post-PCI stent expansion is defined as the minimum stent area divided by the average of proximal and distal reference lumen areas x 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Mean Stent Expansion (%)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Mean stent expansion is defined as the mean stent area (stent volume/analyzed stent length) divided by the average of proximal and distal reference lumen areas x 100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Plaque Protrusion and Thrombus</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Plaque protrusion and thrombus is defined as a mass attached to the luminal surface or floating within the lumen, meeting the following criteria:&#xD;
Protrusion is defined as any mass at least 0.2 mm beyond the luminal edge of a strut and will be further classified as Major and Minor.&#xD;
Major: Protrusion area/Stent area at site of tissue protrusion ≥10%&#xD;
Minor: Protrusion area/Stent area at site of tissue protrusion&lt;10%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Untreated Reference Segment Disease</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Untreated reference segment disease is defined as untreated Mean Lumen Area (MLA) ≤60% of the adjacent reference segment lumen area up to 10 mm from the proximal and distal stent edges.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Edge Dissections</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Edge Dissections are classified as&#xD;
A) Major (%): ≥60 degrees of the circumference of the vessel at site of dissection and/or ≥3 mm in length&#xD;
B) Minor (%): any visible edge dissection &lt;60 degrees of the circumference of the vessel and &lt; 3 mm in length&#xD;
C) All (Major and Minor)&#xD;
Edge dissections will be further classified as:&#xD;
I. Intimal (limited to the intima layer, i.e. not extending beyond the internal elastic lamina)&#xD;
II. Medial (extending into the media layer)&#xD;
III. Adventitial (extending through the external elastic membrane</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Stent Malapposition</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Frequency (%) of incompletely apposed stent struts (defined as stent struts clearly separated from the vessel wall (lumen border/plaque surface) without any tissue behind the struts with a distance from the adjacent intima of ≥0.2 mm and not associated with any side branch).&#xD;
Malapposition will be further classified as:&#xD;
Major: if associated with unacceptable stent expansion&#xD;
Minor: if not associated with significant under-expansion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Border Detection (OCT Arm Only)</measure>
    <time_frame>Pre-PCI OCT Run procedure</time_frame>
    <description>The visibility of the vessel external elastic lamina (EEL) border by OCT will be evaluated at both reference sites (proximal and distal) and the MSA before AND after intervention and then classified into 3 grades:&#xD;
A) Good: ≥75% (270°) of visible circumference&#xD;
B) Moderate: ≥50% (180°) - &lt;75% (270°) of visible circumference&#xD;
C) Poor: &lt;50% (180°) of visible circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Altered Clinical Decision Making on the Basis of the Post-stent Imaging Run</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Clinical decision making will be assessed on the basis of the post-stent imaging run</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Intra-stent Lumen Area (Intra-stent Flow Area)</measure>
    <time_frame>Up to 1 hour post-procedure</time_frame>
    <description>Intra-stent Lumen Area (Intra-stent Flow Area) is defined as stent area minus any protrusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Effective Lumen Area (Total Flow Area)</measure>
    <time_frame>Up to 1 hour post-procedure</time_frame>
    <description>Effective lumen area (Total flow area) is defined as Intra-stent Lumen Area plus any area of malapposition between the stent and the vessel wall (lumen border/plaque border).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVUS Secondary Endpoints: Comparison of Number of Participants With Dissection IVUS vs. OCT Imaging (IVUS Arm Only)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Dissection (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVUS Secondary Endpoints: Comparison of Number of Participants With Malapposition IVUS vs. OCT Imaging (IVUS Arm Only)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Malapposition (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVUS Secondary Endpoints: Comparison of Number of Participants With Plaque or Thrombus Protrusion IVUS vs. OCT Imaging (IVUS Arm Only)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Protrusion (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</measure>
    <time_frame>Baseline</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</measure>
    <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</measure>
    <time_frame>Baseline</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</measure>
    <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints (Angiographic Endpoints (QCA)) - Median Acute Lumen Gain Post-intervention</measure>
    <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Acute lumen gain post-intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</measure>
    <time_frame>Baseline</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</measure>
    <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Number of Participants With Angiographic Dissection ≥ NHLBI Type B</measure>
    <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
    <description>Angiographic Endpoints (QCA) will be assessed as Angiographic dissection ≥ NHLBI type B</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported): Median Total Stent Length</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Median Total Stent Length will be measured in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported): Median Stents Per Lesion</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Median Stents per lesion will be measured in counts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported) - Median Maximal Stent Size</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Median Maximal stent size will be measured in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported) - Median Post-dilatation Inflations</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Post dilatation inflations will be assessed in terms of use of balloon inflations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported): Median Maximum Inflation Pressure (Atm.)</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Median Maximum inflation pressure will be measured in atm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Endpoints (Site Reported): Number of Participants With Additional Interventions</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Participants will be analyzed for the use of additional inventions&#xD;
Additional interventions used on the basis of the post stent imaging run will be either use of Larger Balloon, Use of Higher Inflation Pressures, Use of Additional Inflations, Use of Additional Stent(s), Thrombus Aspiration, or Other Interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Procedural and Clinical Endpoints: Number of Participants With Angiography Defined Procedural Success Rate</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Angiography defined procedural success rate is defined as a final lesion angiographic diameter stenosis &lt;30% (QCA) and TIMI III flow (QCA) without dissection ≥ NHLBI type C, perforation, prolonged chest pain or ST segment elevation or depression changes (&gt;30 minutes), or procedural death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Procedural and Clinical Endpoints - Number of Participants With Device Success Rate</measure>
    <time_frame>During procedure, an average of 1 hour</time_frame>
    <description>Device success rate (site reported):&#xD;
Successful OCT or IVUS imaging obtained pre and post PCI in the respective arms (does not include blinded OCT runs in the IVUS and Angiography arms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Procedural and Clinical Endpoints - Number of Participants With Target Lesion Failure (TLF)</measure>
    <time_frame>1 year</time_frame>
    <description>Target Lesion Failure (TLF) at 1 year defined as cardiovascular death, target vessel myocardial infarction, or ischemia driven target-lesion revascularization.&#xD;
Target lesion is defined as the lesion designated for randomization to OCT vs. IVUS vs. Angiography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional Procedural and Clinical Endpoints - Number of Participants With Peri-procedural Myocardial Infarction</measure>
    <time_frame>1 Year</time_frame>
    <description>Number of Participants With Periprocedural Myocardial Infarction will be assessed at 1 year</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">450</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Coronary PCI guided by IVUS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coronary PCI guided by OCT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coronary PCI guided by Angiography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary PCI guided by IVUS</intervention_name>
    <description>Imaging type</description>
    <arm_group_label>Coronary PCI guided by IVUS</arm_group_label>
    <other_name>Intravascular Ultrasound</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary PCI guided by OCT</intervention_name>
    <description>Imaging type</description>
    <arm_group_label>Coronary PCI guided by OCT</arm_group_label>
    <other_name>Optical Coherence Tomography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary PCI guided by Angiography</intervention_name>
    <description>Imaging type</description>
    <arm_group_label>Coronary PCI guided by Angiography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        General Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥ 18 years.&#xD;
&#xD;
          2. Patient with an indication for PCI including:&#xD;
&#xD;
               -  Angina (stable or unstable),&#xD;
&#xD;
               -  Silent ischemia (a visually estimated target lesion diameter stenosis of ≥70%, a&#xD;
                  positive non-invasive stress test, or FFR ≤0.80 must be present),&#xD;
&#xD;
               -  NSTEMI, or&#xD;
&#xD;
               -  Recent STEMI (&gt;24 hours from initial presentation and stable).&#xD;
&#xD;
          3. Patients will undergo cardiac catheterization and possible or definite PCI with intent&#xD;
             to stent using any non-investigational metallic drug-eluting stent (DES)&#xD;
&#xD;
          4. Signed written informed consent&#xD;
&#xD;
        Angiographic inclusion criteria:&#xD;
&#xD;
          1. The target lesion must be located in a native coronary artery with visually estimated&#xD;
             reference vessel diameter of ≥2.25 mm to ≤3.50 mm.&#xD;
&#xD;
          2. Lesion length &lt;40mm&#xD;
&#xD;
        General Exclusion Criteria:&#xD;
&#xD;
          1. Estimated creatinine clearance &lt;30 ml/min using Cockcroft-Gault equation, unless the&#xD;
             patient is on dialysis&#xD;
&#xD;
          2. STEMI within 24 hours of initial time of presentation to the first treating hospital,&#xD;
             whether at a transfer facility or the study hospital.&#xD;
&#xD;
          3. PCI within 24 hours preceding the study procedure.&#xD;
&#xD;
          4. PCI of a lesion within the target vessel within 12 months prior to the study procedure&#xD;
&#xD;
          5. Planned use of bare metal stent (BMS)&#xD;
&#xD;
          6. Planned use of bioresorbable vascular scaffold (BVS)&#xD;
&#xD;
          7. Cardiogenic shock (defined as persistent hypotension (systolic blood pressure &lt;90&#xD;
             mm/Hg for more than 30 minutes) or requiring pressors or hemodynamic support,&#xD;
             including IABP, at time of procedure.&#xD;
&#xD;
          8. Mobitz II second degree or complete heart block&#xD;
&#xD;
          9. Malignant ventricular arrhythmias requiring treatment&#xD;
&#xD;
         10. Pulmonary edema defined as patient with shortness of breath, evidence of volume&#xD;
             overload on physical exam, and crepitations on physical exam (&gt;1/3 of lungs) or&#xD;
             radiographic interstitial or alveolar pulmonary edema&#xD;
&#xD;
         11. Subject is intubated.&#xD;
&#xD;
         12. Known LVEF &lt;30%.&#xD;
&#xD;
         13. Severe valvular disease (e.g. severe mitral regurgitation or severe aortic stenosis)&#xD;
&#xD;
         14. Cerebrovascular accident or transient ischemic attack within the past 6 months, or any&#xD;
             permanent neurologic defect attributed to CVA.&#xD;
&#xD;
         15. Presence of one or more co-morbidities which reduces life expectancy to less than 12&#xD;
             months or may interfere with protocol study processes.&#xD;
&#xD;
         16. Known allergy to protocol-required concomitant medications including aspirin;&#xD;
             clopidogrel, prasugrel, and ticagrelor; heparin and bivalirudin; or iodinated contrast&#xD;
             that cannot be adequately pre-medicated.&#xD;
&#xD;
         17. Patient is participating in any other investigational drug or device clinical trial&#xD;
             that has not reached its primary endpoint.&#xD;
&#xD;
         18. Women who are pregnant or breastfeeding (women of child-bearing potential must have a&#xD;
             negative pregnancy test within one week before treatment).&#xD;
&#xD;
        Angiographic Exclusion Criteria:&#xD;
&#xD;
          1. The presence of any non-study lesion in the target vessel with angiographic diameter&#xD;
             stenosis &gt;50%, or any additional target vessel stenosis which requires PCI either&#xD;
             during or within 12 months after the study procedure&#xD;
&#xD;
          2. Left main diameter stenosis ≥30% or left main PCI planned.&#xD;
&#xD;
          3. Study target lesion in a bypass graft&#xD;
&#xD;
          4. Ostial RCA study target lesion&#xD;
&#xD;
          5. Chronic total occlusion (TIMI flow 0/1) study target lesion&#xD;
&#xD;
          6. Bifurcation study lesion with a planned dual stent strategy&#xD;
&#xD;
          7. In-stent restenosis study target lesion&#xD;
&#xD;
          8. Any study lesion characteristic resulting in the expected inability to deliver the&#xD;
             IVUS or OCT catheter to the lesion pre and post PCI (e.g. moderate or severe vessel&#xD;
             calcification or tortuosity)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziad Ali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia Presbyterian Medical Center (NY)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gregg W Stone, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia Presbyterian Medical Center (NY)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital - Univ. of Alabama at Birmingham (UAB)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scottsdale Healthcare Shea</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego (UCSD) Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Institute of Colorado</name>
      <address>
        <city>Broomfield</city>
        <state>Colorado</state>
        <zip>80021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital/Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Cardiology</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INTEGRIS Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Charles Medical Center</name>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onze-Lieve-Vrouwziekenhuis Campus Aalst</name>
      <address>
        <city>Aalst</city>
        <state>East Flanders</state>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Justus-Liebig-Universität</name>
      <address>
        <city>Giessen</city>
        <state>Hesse</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Papa Giovanni XXIII</name>
      <address>
        <city>Bergamo</city>
        <state>Lombardy</state>
        <zip>24127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milan</city>
        <state>Lombardy</state>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kobe University Hospital</name>
      <address>
        <city>Chuo-ku</city>
        <state>Hyogo</state>
        <zip>650-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nara Medical University Hospital</name>
      <address>
        <city>Kashihara-shi</city>
        <state>Nara</state>
        <zip>634-8521</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Saiseikai Nakatsu Hospital</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>530-0012</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wakayama Medical University Hospital</name>
      <address>
        <city>Wakayama City</city>
        <state>Wakayama</state>
        <zip>641-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yamaguchi University Hospital</name>
      <address>
        <city>Ube-shi</city>
        <state>Yamaguchi</state>
        <zip>755-0046</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - Thoraxcenter</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de la Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings College Hospital</name>
      <address>
        <city>Brixton</city>
        <state>London</state>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2015</study_first_posted>
  <results_first_submitted>January 4, 2021</results_first_submitted>
  <results_first_submitted_qc>March 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 1, 2021</results_first_posted>
  <last_update_submitted>March 5, 2021</last_update_submitted>
  <last_update_submitted_qc>March 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Intravascular Ultrasound</keyword>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>SJM-CIP-10034</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 1,759 subjects were initially consented, however only 450 subjects were actually randomized and enrolled into the trial across 29 sites. The first randomized subject was enrolled on May 13, 2015, and the last randomized subject was enrolled on April 5, 2016. Each site was allowed to enroll a maximum of 65 subjects in the trial. The subjects were followed through 12-months and the last subject follow-up visit was completed on April 25, 2017.</recruitment_details>
      <pre_assignment_details>Of the 1759 subjects consented, 1309 subjects were not randomized due to failed screening (n=1230), roll-in subjects (n=74), withdrawal of consent (n=1), withdrawal by the investigator (n=3) and software malfunction (n=1).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Coronary PCI Guided by OCT</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
        </group>
        <group group_id="P2">
          <title>Coronary PCI Guided by IVUS</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
        </group>
        <group group_id="P3">
          <title>Coronary PCI Guided by Angiography</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="158"/>
                <participants group_id="P2" count="146"/>
                <participants group_id="P3" count="146"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="153"/>
                <participants group_id="P2" count="136"/>
                <participants group_id="P3" count="142"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Coronary PCI Guided by OCT</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
        </group>
        <group group_id="B2">
          <title>Coronary PCI Guided by IVUS</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
        </group>
        <group group_id="B3">
          <title>Coronary PCI Guided by Angiography</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="158"/>
            <count group_id="B2" value="146"/>
            <count group_id="B3" value="146"/>
            <count group_id="B4" value="450"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.5" spread="9.3"/>
                    <measurement group_id="B2" value="65.8" spread="9.5"/>
                    <measurement group_id="B3" value="65.4" spread="11.2"/>
                    <measurement group_id="B4" value="65.6" spread="10.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="127"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="109"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="107"/>
                    <measurement group_id="B4" value="323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Belgium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="85"/>
                    <measurement group_id="B4" value="255"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japan</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="32"/>
                    <measurement group_id="B4" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="158"/>
                    <count group_id="B2" value="146"/>
                    <count group_id="B3" value="146"/>
                    <count group_id="B4" value="450"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Efficacy Endpoint (Powered): Post-PCI Median Minimum Stent Area (MSA)</title>
        <description>Post-PCI MSA will be assessed by OCT in each randomized arm, measured at the independent OCT core laboratory blinded to imaging modality assignment. Hierarchal manner testing will be as follows:&#xD;
Non-inferiority: OCT vs. IVUS guided stenting&#xD;
Non-inferiority of OCT guided stenting to IVUS guided stenting will be analyzed for the mean difference between the post PCI MSA for the OCT and IVUS arms with non-inferiority margin of 1.0 mm^2.&#xD;
Superiority: OCT vs. Angiography guided stenting&#xD;
If the OCT guided stenting arm was found to be non-inferior to the IVUS guided stenting arm, the superiority of OCT to angiography will be tested for the mean difference between the post PCI MSA for the OCT and angiography arms.&#xD;
Superiority: OCT vs. IVUS guided stenting&#xD;
If the OCT guided stenting arm was found to be superior to the IVUS guided stenting arm, then the superiority of OCT to IVUS will be tested for the mean difference between the post PCI MSA for the OCT and IVUS arms.</description>
        <time_frame>Post-procedure within 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Efficacy Endpoint (Powered): Post-PCI Median Minimum Stent Area (MSA)</title>
          <description>Post-PCI MSA will be assessed by OCT in each randomized arm, measured at the independent OCT core laboratory blinded to imaging modality assignment. Hierarchal manner testing will be as follows:&#xD;
Non-inferiority: OCT vs. IVUS guided stenting&#xD;
Non-inferiority of OCT guided stenting to IVUS guided stenting will be analyzed for the mean difference between the post PCI MSA for the OCT and IVUS arms with non-inferiority margin of 1.0 mm^2.&#xD;
Superiority: OCT vs. Angiography guided stenting&#xD;
If the OCT guided stenting arm was found to be non-inferior to the IVUS guided stenting arm, the superiority of OCT to angiography will be tested for the mean difference between the post PCI MSA for the OCT and angiography arms.&#xD;
Superiority: OCT vs. IVUS guided stenting&#xD;
If the OCT guided stenting arm was found to be superior to the IVUS guided stenting arm, then the superiority of OCT to IVUS will be tested for the mean difference between the post PCI MSA for the OCT and IVUS arms.</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>mm^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.79" lower_limit="4.54" upper_limit="7.34"/>
                    <measurement group_id="O2" value="5.89" lower_limit="4.67" upper_limit="7.80"/>
                    <measurement group_id="O3" value="5.49" lower_limit="4.39" upper_limit="6.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Safety Endpoint (Non-powered): Number of Participants With Procedural MACE (Major Adverse Cardiac Event)</title>
        <description>Procedural MACE defined as procedural complications (angiographic dissection, perforation, thrombus, and acute closure) requiring active interventions (prolonged balloon inflations, additional stent implantations, pericardiocentesis, thrombus aspiration and other).</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Safety Endpoint (Non-powered): Number of Participants With Procedural MACE (Major Adverse Cardiac Event)</title>
          <description>Procedural MACE defined as procedural complications (angiographic dissection, perforation, thrombus, and acute closure) requiring active interventions (prolonged balloon inflations, additional stent implantations, pericardiocentesis, thrombus aspiration and other).</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Intra-Procedural Complications Required Active Interventions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prolonged Balloon Inflations</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Stent implantation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pericardiocentesis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thrombus Aspiration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Interventions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Acute Procedural Success</title>
        <description>Acute procedural success are classified as:&#xD;
A) Optimal (%)&#xD;
The MSA of the proximal segment is ≥95% of the proximal reference lumen area and the MSA of the distal segment is ≥95% of the distal reference lumen area.&#xD;
B) Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
C) Optimal and Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
D) Unacceptable (%)&#xD;
The MSA of the proximal segment is &lt;90% of the proximal lumen area, and/or the MSA of the distal segment is &lt;90% of the distal reference lumen area.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Acute Procedural Success</title>
          <description>Acute procedural success are classified as:&#xD;
A) Optimal (%)&#xD;
The MSA of the proximal segment is ≥95% of the proximal reference lumen area and the MSA of the distal segment is ≥95% of the distal reference lumen area.&#xD;
B) Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
C) Optimal and Acceptable (%)&#xD;
The MSA of the proximal segment is ≥90% and &lt;95% of the proximal reference lumen area and the MSA of the distal segment is ≥90% and &lt;95% of the distal reference lumen area.&#xD;
D) Unacceptable (%)&#xD;
The MSA of the proximal segment is &lt;90% of the proximal lumen area, and/or the MSA of the distal segment is &lt;90% of the distal reference lumen area.</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Optimal (≥95%)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="140"/>
                    <count group_id="O2" value="130"/>
                    <count group_id="O3" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptable (90 to 95%)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="140"/>
                    <count group_id="O2" value="135"/>
                    <count group_id="O3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unacceptable (&lt;90%)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="140"/>
                    <count group_id="O2" value="135"/>
                    <count group_id="O3" value="140"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                    <measurement group_id="O2" value="82"/>
                    <measurement group_id="O3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Post-PCI Stent Expansion (%)</title>
        <description>Post-PCI stent expansion is defined as the minimum stent area divided by the average of proximal and distal reference lumen areas x 100.</description>
        <time_frame>Up to 1 hour post-procedure</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Post-PCI Stent Expansion (%)</title>
          <description>Post-PCI stent expansion is defined as the minimum stent area divided by the average of proximal and distal reference lumen areas x 100.</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis.</population>
          <units>percentage of stent expansion</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.6" spread="16.6"/>
                    <measurement group_id="O2" value="86.5" spread="15.9"/>
                    <measurement group_id="O3" value="82.9" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Mean Stent Expansion (%)</title>
        <description>Mean stent expansion is defined as the mean stent area (stent volume/analyzed stent length) divided by the average of proximal and distal reference lumen areas x 100.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Mean Stent Expansion (%)</title>
          <description>Mean stent expansion is defined as the mean stent area (stent volume/analyzed stent length) divided by the average of proximal and distal reference lumen areas x 100.</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>percentage of mean stent expansion</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105.8" lower_limit="97.8" upper_limit="119.8"/>
                    <measurement group_id="O2" value="106.3" lower_limit="96.7" upper_limit="116.6"/>
                    <measurement group_id="O3" value="101.4" lower_limit="91.9" upper_limit="110.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Plaque Protrusion and Thrombus</title>
        <description>Plaque protrusion and thrombus is defined as a mass attached to the luminal surface or floating within the lumen, meeting the following criteria:&#xD;
Protrusion is defined as any mass at least 0.2 mm beyond the luminal edge of a strut and will be further classified as Major and Minor.&#xD;
Major: Protrusion area/Stent area at site of tissue protrusion ≥10%&#xD;
Minor: Protrusion area/Stent area at site of tissue protrusion&lt;10%</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Plaque Protrusion and Thrombus</title>
          <description>Plaque protrusion and thrombus is defined as a mass attached to the luminal surface or floating within the lumen, meeting the following criteria:&#xD;
Protrusion is defined as any mass at least 0.2 mm beyond the luminal edge of a strut and will be further classified as Major and Minor.&#xD;
Major: Protrusion area/Stent area at site of tissue protrusion ≥10%&#xD;
Minor: Protrusion area/Stent area at site of tissue protrusion&lt;10%</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="73"/>
                    <measurement group_id="O3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Untreated Reference Segment Disease</title>
        <description>Untreated reference segment disease is defined as untreated Mean Lumen Area (MLA) ≤60% of the adjacent reference segment lumen area up to 10 mm from the proximal and distal stent edges.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Untreated Reference Segment Disease</title>
          <description>Untreated reference segment disease is defined as untreated Mean Lumen Area (MLA) ≤60% of the adjacent reference segment lumen area up to 10 mm from the proximal and distal stent edges.</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Edge Dissections</title>
        <description>Edge Dissections are classified as&#xD;
A) Major (%): ≥60 degrees of the circumference of the vessel at site of dissection and/or ≥3 mm in length&#xD;
B) Minor (%): any visible edge dissection &lt;60 degrees of the circumference of the vessel and &lt; 3 mm in length&#xD;
C) All (Major and Minor)&#xD;
Edge dissections will be further classified as:&#xD;
I. Intimal (limited to the intima layer, i.e. not extending beyond the internal elastic lamina)&#xD;
II. Medial (extending into the media layer)&#xD;
III. Adventitial (extending through the external elastic membrane</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Edge Dissections</title>
          <description>Edge Dissections are classified as&#xD;
A) Major (%): ≥60 degrees of the circumference of the vessel at site of dissection and/or ≥3 mm in length&#xD;
B) Minor (%): any visible edge dissection &lt;60 degrees of the circumference of the vessel and &lt; 3 mm in length&#xD;
C) All (Major and Minor)&#xD;
Edge dissections will be further classified as:&#xD;
I. Intimal (limited to the intima layer, i.e. not extending beyond the internal elastic lamina)&#xD;
II. Medial (extending into the media layer)&#xD;
III. Adventitial (extending through the external elastic membrane</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All (Major and Minor)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intimal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Medial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="45"/>
                    <measurement group_id="O3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adventitial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Stent Malapposition</title>
        <description>Frequency (%) of incompletely apposed stent struts (defined as stent struts clearly separated from the vessel wall (lumen border/plaque surface) without any tissue behind the struts with a distance from the adjacent intima of ≥0.2 mm and not associated with any side branch).&#xD;
Malapposition will be further classified as:&#xD;
Major: if associated with unacceptable stent expansion&#xD;
Minor: if not associated with significant under-expansion</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Stent Malapposition</title>
          <description>Frequency (%) of incompletely apposed stent struts (defined as stent struts clearly separated from the vessel wall (lumen border/plaque surface) without any tissue behind the struts with a distance from the adjacent intima of ≥0.2 mm and not associated with any side branch).&#xD;
Malapposition will be further classified as:&#xD;
Major: if associated with unacceptable stent expansion&#xD;
Minor: if not associated with significant under-expansion</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All (Major and Minor)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Border Detection (OCT Arm Only)</title>
        <description>The visibility of the vessel external elastic lamina (EEL) border by OCT will be evaluated at both reference sites (proximal and distal) and the MSA before AND after intervention and then classified into 3 grades:&#xD;
A) Good: ≥75% (270°) of visible circumference&#xD;
B) Moderate: ≥50% (180°) - &lt;75% (270°) of visible circumference&#xD;
C) Poor: &lt;50% (180°) of visible circumference</description>
        <time_frame>Pre-PCI OCT Run procedure</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention =Coronary stenting with planned drug eluting stent (DES). Stenting will be performed with IVUS guidance according to local standard practice.IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed. After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS:Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES). Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography:Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Border Detection (OCT Arm Only)</title>
          <description>The visibility of the vessel external elastic lamina (EEL) border by OCT will be evaluated at both reference sites (proximal and distal) and the MSA before AND after intervention and then classified into 3 grades:&#xD;
A) Good: ≥75% (270°) of visible circumference&#xD;
B) Moderate: ≥50% (180°) - &lt;75% (270°) of visible circumference&#xD;
C) Poor: &lt;50% (180°) of visible circumference</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="144"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Poor &lt;180º of Visible EEL Circumference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Moderate &gt;=1800, &lt;2700 of Visible EEL Circumference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good &gt;=2700 of Visible EEL Circumference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="109"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Altered Clinical Decision Making on the Basis of the Post-stent Imaging Run</title>
        <description>Clinical decision making will be assessed on the basis of the post-stent imaging run</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Altered Clinical Decision Making on the Basis of the Post-stent Imaging Run</title>
          <description>Clinical decision making will be assessed on the basis of the post-stent imaging run</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>OCT/IVUS Result Acceptable (Yes)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="78"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>OCT/IVUS Result Acceptable (No)</title>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="62"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Intra-stent Lumen Area (Intra-stent Flow Area)</title>
        <description>Intra-stent Lumen Area (Intra-stent Flow Area) is defined as stent area minus any protrusion</description>
        <time_frame>Up to 1 hour post-procedure</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Median Intra-stent Lumen Area (Intra-stent Flow Area)</title>
          <description>Intra-stent Lumen Area (Intra-stent Flow Area) is defined as stent area minus any protrusion</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>mm^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.54" lower_limit="4.34" upper_limit="7.05"/>
                    <measurement group_id="O2" value="5.71" lower_limit="4.59" upper_limit="7.58"/>
                    <measurement group_id="O3" value="5.42" lower_limit="4.25" upper_limit="6.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Effective Lumen Area (Total Flow Area)</title>
        <description>Effective lumen area (Total flow area) is defined as Intra-stent Lumen Area plus any area of malapposition between the stent and the vessel wall (lumen border/plaque border).</description>
        <time_frame>Up to 1 hour post-procedure</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Median Effective Lumen Area (Total Flow Area)</title>
          <description>Effective lumen area (Total flow area) is defined as Intra-stent Lumen Area plus any area of malapposition between the stent and the vessel wall (lumen border/plaque border).</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>mm^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="140"/>
                <count group_id="O2" value="135"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.68" lower_limit="4.59" upper_limit="7.30"/>
                    <measurement group_id="O2" value="5.87" lower_limit="4.76" upper_limit="7.59"/>
                    <measurement group_id="O3" value="5.52" lower_limit="4.42" upper_limit="6.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Dissection IVUS vs. OCT Imaging (IVUS Arm Only)</title>
        <description>Dissection (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Dissection IVUS vs. OCT Imaging (IVUS Arm Only)</title>
          <description>Dissection (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="134"/>
                    <count group_id="O2" value="137"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="134"/>
                    <count group_id="O2" value="137"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All (Major and Minor)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="134"/>
                    <count group_id="O2" value="137"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Malapposition IVUS vs. OCT Imaging (IVUS Arm Only)</title>
        <description>Malapposition (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Malapposition IVUS vs. OCT Imaging (IVUS Arm Only)</title>
          <description>Malapposition (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All (Major and Minor)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Plaque or Thrombus Protrusion IVUS vs. OCT Imaging (IVUS Arm Only)</title>
        <description>Protrusion (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>IVUS Secondary Endpoints: Comparison of Number of Participants With Plaque or Thrombus Protrusion IVUS vs. OCT Imaging (IVUS Arm Only)</title>
          <description>Protrusion (Major, Minimal, All) will be compared between IVUS and OCT Imaging cohorts</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="140"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Major</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Minor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All (Major and Minor)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
        <time_frame>Baseline</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.99" lower_limit="0.70" upper_limit="1.24"/>
                    <measurement group_id="O2" value="1.03" lower_limit="0.73" upper_limit="1.26"/>
                    <measurement group_id="O3" value="0.95" lower_limit="0.68" upper_limit="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
        <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Minimal Lumen Diameter</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Minimal lumen diameter</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>In-stent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.71" lower_limit="2.40" upper_limit="3.05"/>
                    <measurement group_id="O2" value="2.78" lower_limit="2.54" upper_limit="3.09"/>
                    <measurement group_id="O3" value="2.71" lower_limit="2.44" upper_limit="2.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In-segment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" lower_limit="2.03" upper_limit="2.59"/>
                    <measurement group_id="O2" value="2.41" lower_limit="2.12" upper_limit="2.74"/>
                    <measurement group_id="O3" value="2.37" lower_limit="2.11" upper_limit="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</title>
        <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
        <time_frame>Baseline</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</title>
          <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>percentage of Diameter Stenosis</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.1" lower_limit="55.8" upper_limit="73.1"/>
                    <measurement group_id="O2" value="63.7" lower_limit="56.0" upper_limit="73.0"/>
                    <measurement group_id="O3" value="66.0" lower_limit="57.8" upper_limit="74.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</title>
        <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
        <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Diameter Stenosis</title>
          <description>Angiographic Endpoints (QCA) will be assessed as diameter stenosis</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>percentage of Diameter Stenosis</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>In-stent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" lower_limit="2.2" upper_limit="10.6"/>
                    <measurement group_id="O2" value="5.1" lower_limit="2.6" upper_limit="8.6"/>
                    <measurement group_id="O3" value="6.2" lower_limit="2.5" upper_limit="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In-segment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.7" lower_limit="9.6" upper_limit="22.9"/>
                    <measurement group_id="O2" value="13.4" lower_limit="9.0" upper_limit="20.3"/>
                    <measurement group_id="O3" value="13.0" lower_limit="8.7" upper_limit="18.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints (Angiographic Endpoints (QCA)) - Median Acute Lumen Gain Post-intervention</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Acute lumen gain post-intervention</description>
        <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints (Angiographic Endpoints (QCA)) - Median Acute Lumen Gain Post-intervention</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Acute lumen gain post-intervention</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>In-stent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" lower_limit="1.45" upper_limit="2.05"/>
                    <measurement group_id="O2" value="1.75" lower_limit="1.52" upper_limit="2.10"/>
                    <measurement group_id="O3" value="1.75" lower_limit="1.48" upper_limit="2.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>In-segment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" lower_limit="1.02" upper_limit="1.65"/>
                    <measurement group_id="O2" value="1.38" lower_limit="1.15" upper_limit="1.71"/>
                    <measurement group_id="O3" value="1.36" lower_limit="1.16" upper_limit="1.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
        <time_frame>Baseline</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.78" lower_limit="2.42" upper_limit="3.12"/>
                    <measurement group_id="O2" value="2.87" lower_limit="2.56" upper_limit="3.17"/>
                    <measurement group_id="O3" value="2.76" lower_limit="2.50" upper_limit="3.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
        <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Median Maximum Stent Size/Reference Vessel Diameter Ratio</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Maximum stent size/reference vessel diameter ratio. Maximum stent size refers to the largest stent diameter used in a treated segment. If only one stent was used, it is that stent diameter. If more than one stent were used, it is the larger of the stent diameters.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.82" lower_limit="2.47" upper_limit="3.13"/>
                    <measurement group_id="O2" value="2.84" lower_limit="2.58" upper_limit="3.17"/>
                    <measurement group_id="O3" value="2.72" lower_limit="2.45" upper_limit="3.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Number of Participants With Angiographic Dissection ≥ NHLBI Type B</title>
        <description>Angiographic Endpoints (QCA) will be assessed as Angiographic dissection ≥ NHLBI type B</description>
        <time_frame>Final Post-PCI, up to 1 hour after PCI procedure</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Non OCT Secondary Endpoints - Angiographic Endpoints (QCA): Number of Participants With Angiographic Dissection ≥ NHLBI Type B</title>
          <description>Angiographic Endpoints (QCA) will be assessed as Angiographic dissection ≥ NHLBI type B</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported): Median Total Stent Length</title>
        <description>Median Total Stent Length will be measured in millimeters.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported): Median Total Stent Length</title>
          <description>Median Total Stent Length will be measured in millimeters.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" lower_limit="15.0" upper_limit="32.0"/>
                    <measurement group_id="O2" value="24.0" lower_limit="16.0" upper_limit="32.0"/>
                    <measurement group_id="O3" value="20.0" lower_limit="16.0" upper_limit="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported): Median Stents Per Lesion</title>
        <description>Median Stents per lesion will be measured in counts</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported): Median Stents Per Lesion</title>
          <description>Median Stents per lesion will be measured in counts</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Stents per lesion</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="1"/>
                    <measurement group_id="O3" value="1" lower_limit="1" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported) - Median Maximal Stent Size</title>
        <description>Median Maximal stent size will be measured in millimeters.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported) - Median Maximal Stent Size</title>
          <description>Median Maximal stent size will be measured in millimeters.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" lower_limit="2.75" upper_limit="3.50"/>
                    <measurement group_id="O2" value="3.00" lower_limit="2.75" upper_limit="3.50"/>
                    <measurement group_id="O3" value="3.00" lower_limit="2.75" upper_limit="3.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported) - Median Post-dilatation Inflations</title>
        <description>Post dilatation inflations will be assessed in terms of use of balloon inflations</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported) - Median Post-dilatation Inflations</title>
          <description>Post dilatation inflations will be assessed in terms of use of balloon inflations</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Number of inflations</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="O3" value="1" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported): Median Maximum Inflation Pressure (Atm.)</title>
        <description>Median Maximum inflation pressure will be measured in atm.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported): Median Maximum Inflation Pressure (Atm.)</title>
          <description>Median Maximum inflation pressure will be measured in atm.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>atm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" lower_limit="16" upper_limit="20"/>
                    <measurement group_id="O2" value="20" lower_limit="16" upper_limit="20"/>
                    <measurement group_id="O3" value="18" lower_limit="16" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Endpoints (Site Reported): Number of Participants With Additional Interventions</title>
        <description>Participants will be analyzed for the use of additional inventions&#xD;
Additional interventions used on the basis of the post stent imaging run will be either use of Larger Balloon, Use of Higher Inflation Pressures, Use of Additional Inflations, Use of Additional Stent(s), Thrombus Aspiration, or Other Interventions</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Endpoints (Site Reported): Number of Participants With Additional Interventions</title>
          <description>Participants will be analyzed for the use of additional inventions&#xD;
Additional interventions used on the basis of the post stent imaging run will be either use of Larger Balloon, Use of Higher Inflation Pressures, Use of Additional Inflations, Use of Additional Stent(s), Thrombus Aspiration, or Other Interventions</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Larger Diameter Balloon</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="82"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Higher Pressure Balloon</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="82"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="40"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Stent</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="82"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other interventions</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="82"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Procedural and Clinical Endpoints: Number of Participants With Angiography Defined Procedural Success Rate</title>
        <description>Angiography defined procedural success rate is defined as a final lesion angiographic diameter stenosis &lt;30% (QCA) and TIMI III flow (QCA) without dissection ≥ NHLBI type C, perforation, prolonged chest pain or ST segment elevation or depression changes (&gt;30 minutes), or procedural death.</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Procedural and Clinical Endpoints: Number of Participants With Angiography Defined Procedural Success Rate</title>
          <description>Angiography defined procedural success rate is defined as a final lesion angiographic diameter stenosis &lt;30% (QCA) and TIMI III flow (QCA) without dissection ≥ NHLBI type C, perforation, prolonged chest pain or ST segment elevation or depression changes (&gt;30 minutes), or procedural death.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135"/>
                    <measurement group_id="O2" value="130"/>
                    <measurement group_id="O3" value="131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Procedural and Clinical Endpoints - Number of Participants With Device Success Rate</title>
        <description>Device success rate (site reported):&#xD;
Successful OCT or IVUS imaging obtained pre and post PCI in the respective arms (does not include blinded OCT runs in the IVUS and Angiography arms)</description>
        <time_frame>During procedure, an average of 1 hour</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Procedural and Clinical Endpoints - Number of Participants With Device Success Rate</title>
          <description>Device success rate (site reported):&#xD;
Successful OCT or IVUS imaging obtained pre and post PCI in the respective arms (does not include blinded OCT runs in the IVUS and Angiography arms)</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="149"/>
                    <measurement group_id="O2" value="139"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Procedural and Clinical Endpoints - Number of Participants With Target Lesion Failure (TLF)</title>
        <description>Target Lesion Failure (TLF) at 1 year defined as cardiovascular death, target vessel myocardial infarction, or ischemia driven target-lesion revascularization.&#xD;
Target lesion is defined as the lesion designated for randomization to OCT vs. IVUS vs. Angiography.</description>
        <time_frame>1 year</time_frame>
        <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Procedural and Clinical Endpoints - Number of Participants With Target Lesion Failure (TLF)</title>
          <description>Target Lesion Failure (TLF) at 1 year defined as cardiovascular death, target vessel myocardial infarction, or ischemia driven target-lesion revascularization.&#xD;
Target lesion is defined as the lesion designated for randomization to OCT vs. IVUS vs. Angiography.</description>
          <population>Full Analysis Set (FAS) consists of all randomized subjects assigned to treatment per randomization.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="158"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Additional Procedural and Clinical Endpoints - Number of Participants With Peri-procedural Myocardial Infarction</title>
        <description>Number of Participants With Periprocedural Myocardial Infarction will be assessed at 1 year</description>
        <time_frame>1 Year</time_frame>
        <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Coronary PCI Guided by OCT</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
          </group>
          <group group_id="O2">
            <title>Coronary PCI Guided by IVUS</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
          </group>
          <group group_id="O3">
            <title>Coronary PCI Guided by Angiography</title>
            <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
          </group>
        </group_list>
        <measure>
          <title>Additional Procedural and Clinical Endpoints - Number of Participants With Peri-procedural Myocardial Infarction</title>
          <description>Number of Participants With Periprocedural Myocardial Infarction will be assessed at 1 year</description>
          <population>The number of participants analyzed includes subjects who were available at that time of analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="146"/>
                <count group_id="O3" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 Year</time_frame>
      <desc>All-Cause Mortality and Serious Adverse Events were monitored and analyzed. Non-serious adverse event information was not monitored for this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Coronary PCI Guided by OCT</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with OCT guidance according to the algorithm described in the protocol. OCT imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final OCT imaging run must be performed.&#xD;
Coronary PCI guided by OCT: Imaging type</description>
        </group>
        <group group_id="E2">
          <title>Coronary PCI Guided by IVUS</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with IVUS guidance according to local standard practice. IVUS imaging is required pre and post stent implantation.&#xD;
At the end of the procedure, a final IVUS imaging run must be performed.&#xD;
After the final IVUS run, a blinded OCT imaging run shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by IVUS: Imaging type</description>
        </group>
        <group group_id="E3">
          <title>Coronary PCI Guided by Angiography</title>
          <description>Intervention = Coronary stenting with planned drug eluting stent (DES).&#xD;
Stenting will be performed with angiography guidance according to local standard practice.&#xD;
At the end of the procedure, a blinded OCT shall be performed to document final stent dimensions and results.&#xD;
Coronary PCI guided by Angiography: Imaging type</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Coronary restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Unstable angina</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Coronary perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Sustained ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Myocardial ischemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal bleeding</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia caused by Gram-Negative Bacilli</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Pneumonia caused by Haemophilus Influenzae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Acute viral hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>In-stent restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Trauma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Elevated troponin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arm pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Colon polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Seizure/convulsions/epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Transient ischemic attack (TIA)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infections</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>VASC vessel perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Vascular dissection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Vasc pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Arterial hypertension/hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Left main dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="146"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="158"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="146"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kristina M Gibbens, Senior Clinical Project Manager</name_or_title>
      <organization>Abbott</organization>
      <phone>+1 651-756-3859</phone>
      <email>Kristina.gibbens@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

